Posted in | News | Photovoltaics

New Front-Side Metallization Pastes for Standard to Ultra-Lightly Doped Emitter Cells from Heraeus

The Heraeus Photovoltaics Business Unit, a worldwide leading supplier of metallization pastes for solar cells, will launch two new front-side metallization pastes for standard to ultra-lightly doped emitter cells - the SOL9620 Series and SOL9621 Series - at the SNEC (2014) International Photovoltaic Power Generation Conference & Exhibition from May 20th through May 22nd, 2014. Heraeus will be exhibiting in Hall W3 at booth 560.

The SOL9620 Series and SOL9621 Series enables cell manufacturers to further improve their c-Si cells' conversion efficiencies to an industry-leading level. By using these new pastes, customers have confirmed efficiency improvements that ranged between 0.05% and 0.20% absolute on lightly doped emitter [90 – 100 ohm/sq.] wafers, relative to the best commercially available front-side pastes. Even greater gains have been achieved on ultra lightly doped emitter [110 ohm/sq.] wafers, where the paste unfolds its peak performance.

The SOL9620 Series and SOL9621 Series of pastes are able to provide excellent contact on lightly doped emitters [LDE]. The SOL9620 Series is outstanding for ultra-lightly doped emitters [ULDE], with surface doping concentrations down to 1xE20/cm3. "The SOL9620 Series also has the ability to be fired at a peak temperature 15 K less than standard firing temperatures. This is ideal for PERC applications. The SOL9621 Series has demonstrated great results for LDE applications. The SOL9621 Series provides customers with a flexible process window, which aids in providing a lower manufacturing cost," explains Dr. Weiming Zhang, Vice President of Technology of the Heraeus Photovoltaics Business Unit. He continues to state, "The reduced contact resistance on LDE und ULDE wafers helps yielding increased voltage and higher cell efficiencies. When optimized in a customer's manufacturing process, both pastes provide excellent performance."

"Heraeus has always been a leader in the development of innovative metallization pastes for solar cells. We are launching two products for slightly different LDE applications that provide industry leading cell efficiencies while lowering customers' cost per watt. Having two products allow customers to select the paste that is best for their cell design and manufacturing process," according to Andreas Liebheit, Global Manager of the Heraeus Photovoltaics Business Unit. He continues to state, "The acquisition of the Ferro PV Paste Business in 2013 is enhancing our research and development capabilities and growing our intellectual property portfolio. We have improved our ability to provide our customers with new metallization paste options for a variety of cell design applications."

The SOL9620 Series, the SOL9621 Series, our advancements in paste technology and other topics can be discussed at Heraeus Photovoltaics' celebration event at our booth on Tuesday, May 20th from 3:30pm – 5:30pm at this year's SNEC 8th (2014) International Photovoltaic Power Generation Conference & Exhibition, in Shanghai China at Hall: W3 Booth: 560. You can also go to www.pvsilverpaste.com for more information about our products and selected research presentations.

About the Heraeus Photovoltaics Business Unit

The Heraeus Photovoltaics Business Unit is an industry leading developer and manufacturer of silver metallization pastes for the photovoltaic industry. For over 40 years, Heraeus has built a reputation of innovation, extensive research and new product development in thick film technologies for some of the most prominent companies within a variety of industries. In the field of photovoltaics, the Heraeus Photovoltaics Business Unit applies this history and its innovative technology to offer metallization pastes for solar cell applications. The Heraeus SOL Series of silver pastes is specially formulated to provide higher efficiencies and wider processing windows, resulting in better yields and higher output for cell manufacturers.

The Hanau-based precious metal and technology group Heraeus is a globally active family-run enterprise with a history of more than 160 years. We provide high-end solutions to our customers to lastingly strengthen their competitive position. Our areas of competence include precious metals, materials and technologies, sensors, biomaterials and medical devices, quartz glass and specialty light sources. In the financial year 2013, Heraeus achieved revenues from the sales of products of €3.6 billion, while the revenues from precious metal trading were €13.5 billion. With about 12,500 employees in more than 110 companies world-wide, Heraeus is in a leading position on its global sales markets.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Heraeus Holding GmbH. (2019, February 08). New Front-Side Metallization Pastes for Standard to Ultra-Lightly Doped Emitter Cells from Heraeus. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=41188.

  • MLA

    Heraeus Holding GmbH. "New Front-Side Metallization Pastes for Standard to Ultra-Lightly Doped Emitter Cells from Heraeus". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=41188>.

  • Chicago

    Heraeus Holding GmbH. "New Front-Side Metallization Pastes for Standard to Ultra-Lightly Doped Emitter Cells from Heraeus". AZoM. https://www.azom.com/news.aspx?newsID=41188. (accessed November 23, 2024).

  • Harvard

    Heraeus Holding GmbH. 2019. New Front-Side Metallization Pastes for Standard to Ultra-Lightly Doped Emitter Cells from Heraeus. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=41188.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.